C07D 213/54
Radicals substituted by carbon atoms having three bonds to hetero atoms with
Official title: Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
C07D213/54 (Radicals substituted by carbon atoms having three bonds to hetero atoms with) appears on 2,006 US grants and 1,779 published applications in this corpus.
Search patents in C07D- Granted patents
- 2,006
- Published applications
- 1,779
- Assignees
- 938
- Inventors
- 6,348
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 18 | 0 |
| 1977 | 16 | 0 |
| 1978 | 18 | 0 |
| 1979 | 8 | 0 |
| 1980 | 15 | 0 |
| 1981 | 15 | 0 |
| 1982 | 17 | 0 |
| 1983 | 10 | 0 |
| 1984 | 11 | 0 |
| 1985 | 33 | 0 |
| 1986 | 23 | 0 |
| 1987 | 17 | 0 |
| 1988 | 29 | 0 |
| 1989 | 14 | 0 |
| 1990 | 27 | 0 |
| 1991 | 20 | 0 |
| 1992 | 29 | 0 |
| 1993 | 33 | 0 |
| 1994 | 36 | 0 |
| 1995 | 39 | 0 |
| 1996 | 39 | 0 |
| 1997 | 64 | 0 |
| 1998 | 45 | 0 |
| 1999 | 44 | 0 |
| 2000 | 48 | 0 |
| 2001 | 48 | 9 |
| 2002 | 64 | 56 |
| 2003 | 38 | 71 |
| 2004 | 46 | 86 |
| 2005 | 35 | 59 |
| 2006 | 43 | 57 |
| 2007 | 35 | 78 |
| 2008 | 40 | 63 |
| 2009 | 42 | 86 |
| 2010 | 36 | 91 |
| 2011 | 55 | 65 |
| 2012 | 64 | 64 |
| 2013 | 64 | 73 |
| 2014 | 77 | 108 |
| 2015 | 72 | 88 |
| 2016 | 80 | 94 |
| 2017 | 92 | 79 |
| 2018 | 63 | 69 |
| 2019 | 62 | 72 |
| 2020 | 50 | 72 |
| 2021 | 47 | 60 |
| 2022 | 46 | 50 |
| 2023 | 36 | 82 |
| 2024 | 36 | 63 |
| 2025 | 42 | 56 |
| 2026 | 25 | 28 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- NAMPT modulators29 Sep 2026US 12,747,203 B2Cytokinetics, Inc.
- Reagent for mass spectrometry29 Sep 2026US 12,748,116 B2Roche Diagnostics Operations, Inc.
- Tautomeric ligand enables biomimetic C—H hydroxylation with molecular oxygen22 Sep 2026US 12,741,937 B2The Scripps Research Institute
- Amyloid targeting agents and methods of using the same22 Sep 2026US 12,741,949 B2Amydis, Inc.
- Cancer combination therapies utilizing a nicotinamide phosphoribosyltransferase inhibitor in combination with a nicotinamide adenine dinucleotide salvage pathway precursor25 Aug 2026US 12,714,722 B2Fred Hutchinson Cancer Center
- Novel carboxamide derivatives8 Oct 2026US 2026/0308149 A1Angelini Pharma S.P.A.
- Novel mitofusin inhibitors17 Sep 2026US 2026/0274810 A1Albert Einstein College of Medicine
- Highly water soluble schiff base prodrugs of benzaldehyde allosteric modulators3 Sep 2026US 2026/0256752 A1Illexcor Holdings, LLC
- Additives for electrolytes in li-ion batteries3 Sep 2026US 2026/0260941 A1Hydro-Quebec
- New compound and pharmaceutical composition comprising same27 Aug 2026US 2026/0250262 A1Samjin Pharmaceutical Co., Ltd.
Most cited
By later US patents
- Styryl-substituted pyridyl compounds which inhibit EGF receptor tyrosine kinase174US 5,302,606 ARhone-Poulenc Rorer Pharmaceuticals Inc. · 1994
- Cyclic amides171US 5,698,579 ACelgene Corporation · 1997
- Cyclic amides169US 5,877,200 ACelgene Corporation · 1999
- Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities164US 5,877,207 AAllergan Sales, Inc. · 1999
- Retroviral protease inhibiting compounds159US 5,142,056 AAbbott Laboratories · 1992